Wilson M, Wasserman M, Breton MC, Peloquin F, McDade C, Earnshaw S, Farkouh R. Estimating the clinical and economic impact of switching from the 13-valent to 10-valent pneumococcal conjugate vaccine in Quebec. Poster presented at the Canadian Immunization Conference (CIC) 2018; December 5, 2018. Ottawa, Canada.
Wasserman M, Wilson M, Earnshaw S, McDade C, Pugh S, Moffatt M, Sings H, Hilton B, Farkouh R. Predicting invasive pneumococcal disease incidence: a forecasting approach. Poster presented at the Canadian Immunization Conference (CIC) 2018; December 5, 2018. Previously presented at the 11th International Symposium on Pneumococci and Pneumococcal Diseases.
Earnshaw SR, Brogan AJ, Davis AE. Budget impact analysis II: applications & design issues. Presented at the 2018 ISPOR 21st Annual European Congress; November 11, 2018. Barcelona, Spain. Previously presented at the ISPOR 20th Annual International Meeting.
Mullins CD, Earnshaw SR, Brogan AJ. Budget impact analysis I: a 6-step approach. Presented at the 2018 ISPOR 21st Annual European Congress; November 11, 2018. Barcelona, Spain. Previously presented at the ISPOR 18th Annual European Congress.
Earnshaw SR. Are we ready to use constrained optimization in health outcomes research? - Editorial. Value Health. 2018 Sep;21(9):1029-30. doi: 10.1016/j.jval.2018.07.004
Wilson M, Wasserman M, Jadavi T, Postma M, Breton MC, Peloquin F, Earnshaw S, McDade C, Sings H, Farkouh R. Clinical and economic impact of a potential switch from 13-valent to 10-valent pneumococcal conjugate infant vaccination in Canada. Infect Dis Ther. 2018 Sep;7(3):353-71. doi: 10.1007/s40121-018-0206-1
Earnshaw S. The next level in beta-glucan research: new findings for cholesterol-lowering, gut health and more. Presented at the American Society for Nutrition Conference 2018; June 11, 2018. Boston, MA.
Graham J, Earnshaw S, Burslem K, Lim J. Budget impact analysis of afatinib for first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations in a U.S. health plan. J Manag Care Spec Pharm. 2018 Jun;24(6):544-53. doi: 10.18553/jmcp.2018.24.6.544
Earnshaw SR, Brogan AJ, Brodtkorb TH. Budget impact analysis II – applications and design issues. Presented at the 2018 ISPOR 23rd Annual International Meeting; May 20, 2018. Baltimore, MD. Previously presented at the ISPOR 20th Annual International Meeting.
Mauskopf J, Mullins CD, Earnshaw SR. Budget impact analysis I: a 6-step approach. Presented at the 2018 ISPOR 23rd Annual International Meeting; May 20, 2018. Baltimore, MD. Previously presented at the ISPOR 18th Annual European Congress.
Wilson M, Wasserman M, Earnshaw S, McDade C, Pugh S, Moffatt M, Sings H, Hilton B, Farkouh R. Predicting invasive pneumococcal disease incidence: a forecasting approach. Poster presented at the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD); April 16, 2018. Melbourne, Australia.
Jarmul J, Pletcher MJ, Hassmiller Lich K, Wheeler SB, Weinberger M, Avery CL, Jonas DE, Earnshaw S, Pignone M. Cardiovascular genetic risk testing for targeting statin therapy in the primary prevention of atherosclerotic cardiovascular disease: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004171. doi: 10.1161/CIRCOUTCOMES.117.004171
Mauskopf JA, Standaert B, Earnshaw SR, Connolly M. Changing perspectives, changing values: moving beyond cost-effectiveness analysis. Presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.
Mauskopf JA, Earnshaw SR, Mullins CD. Introduction to budget impact analysis: a 6-step approach. Presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands. Previously presented at the ISPOR 19th Annual International Meeting.
Earnshaw SR, Mullins CD, Brogan AJ, Wolowacz SE. Budget impact analysis: applications and design issues. Presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands. Previously presented at the 2014 ISPOR 19th Annual International Meeting.
Hogue SL, Brogan AP, Earnshaw SR, Khan S, Nelsen S. Academy of Managed Care Pharmacy (AMCP) dossiers: use in health care decision making. Poster presented at the 2014 AMCP Nexus; October 8, 2014. Previously presented at the ISPOR 19th Annual International Conference.
Ward MA, Fang G, Richards K, Walko C, Earnshaw SR, Happe LE, Blalock SJ. Comparative outcomes of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia. Poster presented at the 2014 AMCP Nexus; October 2014.
Kamat SA, Blanchette C, Wilson MR, Tangirala M, Earnshaw SR, Offord S, Gutierrez B, Eramo A, Baker RA. Healthcare cost savings associated with aripiprazole once-monthly (AOM) treatment among schizophrenia patients with psychiatric hospitalizations prior to AOM treatment initiation. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014.
Hogue SL, Brogan AP, Earnshaw SR, Khan SB, Nelsen SH. Academy of Managed Care Pharmacy (AMCP) dossiers: use in health care decision making. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 2, 2014.
Mauskopf JA, Mullins CD, Earnshaw SR. Introduction to budget impact analysis: a 6-step approach. Presented at the 2014 ISPOR 19th Annual International Meeting; June 1, 2014.
Mauskopf JA, Mullins CD, Earnshaw SR, Brogan AJ. Budget impact analysis: applications and design issues. Presented at the 2014 ISPOR 19th Annual International Meeting; June 1, 2014. Montreal, Canada.
Chaiken B, Meyers E, Earnshaw SR, Knighton A. Can we leverage big data for budget impact analysis for real time decision making? Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting; June 2014. Montreal, Canada.
Chaiken B, Meyers EL, Earnshaw S, Knighton AJ. Moving budget impact analysis forward: leveraging big data to enable use in real time operational decision making. Presented at the 2014 ISPOR 19th Annual International Meeting; May 31, 2014. Montreal, Canada.
Pletcher MJ, Pignone M, Earnshaw SR, McDade CL, Phillips KA, Auer R, Zablotska L, Greenland P. Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2014 Mar 1;7(2):276-84. doi: 10.1161/CIRCOUTCOMES.113.000799